Achieving LDL cholesterol target levels <1.81 mmol/L may provide extra cardiovascular protection in patients at high risk: Exploratory analysis of the Standard Versus Intensive Statin Therapy for Patients with Hypercholesterolaemia and Diabetic Retinopathy study.
Hiroshi ItohIssei KomuroMasahiro TakeuchiTakashi AkasakaHiroyuki DaidaYoshiki EgashiraHideo FujitaJitsuo HigakiKen-Ichi HirataShun IshibashiTakaaki IsshikiSadayoshi ItoAtsunori KashiwagiSatoshi KatoKazuo KitagawaMasafumi KitakazeTakanari KitazonoMasahiko KurabayashiKatsumi MiyauchiTomoaki MurakamiToyoaki MuroharaKoichi NodeSusumu OgawaYoshihiko SaitoYoshihiko SeinoTakashi ShigeedaShunya ShindoMasahiro SugawaraSeigo SugiyamaYasuo TerauchiHiroyuki TsutsuiKenji UeshimaKazunori UtsunomiyaMasakazu YamagishiTsutomu YamazakiShoei YoKoutaro YokoteKiyoshi YoshidaMichihiro YoshimuraNagahisa YoshimuraKazuwa NakaoRyozo Nagainull nullPublished in: Diabetes, obesity & metabolism (2018)
This post hoc analysis suggests that achieving LDL cholesterol target levels <1.81 mmol/L may more effectively reduce CV events than achieving target levels ≥2.59 to <3.10 mmol/L in patients with hypercholesterolaemia and diabetic retinopathy.